Qube Research & Technologies LTD Pep Gen Inc. Transaction History
Qube Research & Technologies LTD
- $93.8 Billion
- Q2 2025
A detailed history of Qube Research & Technologies LTD transactions in Pep Gen Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 73,004 shares of PEPG stock, worth $340,198. This represents 0.0% of its overall portfolio holdings.
Number of Shares
73,004Holding current value
$340,198% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding PEPG
# of Institutions
51Shares Held
23.6MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA10.7MShares$49.8 Million0.26% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.76MShares$12.9 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.51MShares$7.03 Million0.0% of portfolio
-
Viking Global Investors LP1.48MShares$6.91 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.35MShares$6.29 Million0.0% of portfolio
About PepGen Inc.
- Ticker PEPG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,631,900
- Market Cap $110M
- Description
- PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...